These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 24056897)

  • 21. Use of 'Pharmaceutical services' Medical Subject Headings (MeSH) in articles assessing pharmacists' interventions.
    Tonin FS; Gmünder V; Bonetti AF; Mendes AM; Fernandez-Llimos F
    Explor Res Clin Soc Pharm; 2022 Sep; 7():100172. PubMed ID: 36082143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International publication trends and collaboration performance of China in healthcare science and services research.
    Chen K; Yao Q; Sun J; He ZF; Yao L; Liu ZY
    Isr J Health Policy Res; 2016; 5():1. PubMed ID: 26834970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. China's health care system reform: Progress and prospects.
    Li L; Fu H
    Int J Health Plann Manage; 2017 Jul; 32(3):240-253. PubMed ID: 28612498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.
    Mekonnen AB; McLachlan AJ; Brien JA
    J Clin Pharm Ther; 2016 Apr; 41(2):128-44. PubMed ID: 26913812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current status of pharmaceutical care provision in tertiary hospitals: results of a cross-sectional survey in China.
    Guo X; Yao D; Liu J; Huang Y; Wang Y; Yao W
    BMC Health Serv Res; 2020 Jun; 20(1):518. PubMed ID: 32513167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical care in Chinese public tertiary hospitals: findings from the 4th National Healthcare Improvement Initiative Survey.
    Li M; Cao M; Sun J; Jiang Y; Liu Y
    Hum Resour Health; 2020 Apr; 18(1):31. PubMed ID: 32345325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health.
    Richardson TE; O'Reilly CL; Chen TF
    Int J Clin Pharm; 2014 Apr; 36(2):222-32. PubMed ID: 24306436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: A systematic review.
    Hazen ACM; de Bont AA; Boelman L; Zwart DLM; de Gier JJ; de Wit NJ; Bouvy ML
    Res Social Adm Pharm; 2018 Mar; 14(3):228-240. PubMed ID: 28506574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services.
    Castelino RL; Bajorek BV; Chen TF
    Ann Pharmacother; 2009 Jun; 43(6):1096-106. PubMed ID: 19470856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
    Zhu D; Shi X; Nicholas S; Bai Q; He P
    BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of China's national essential medicines policy.
    Guan X; Liang H; Xue Y; Shi L
    J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health and health system impacts of China's comprehensive primary healthcare reforms: a systematic review.
    Cai C; Xiong S; Millett C; Xu J; Tian M; Hone T
    Health Policy Plan; 2023 Oct; 38(9):1064-1078. PubMed ID: 37506039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systematic review of the implementation and evaluation of Pharmaceutical Care in hospitalised patients(Pharmaceutical Care implementation in hospitalised patients. Systematic review)].
    Silva-Castro MM; Tuneu I Valls L; Faus MJ
    Farm Hosp; 2010; 34(3):106-24. PubMed ID: 20471570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces.
    Chen W; Tang S; Sun J; Ross-Degnan D; Wagner AK
    BMC Health Serv Res; 2010 Jul; 10():211. PubMed ID: 20637116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comprehensive measure of pharmaceutical services: the pharmaceutical-care index.
    Pitterle ME; Bond CA; Raehl CL
    Am J Hosp Pharm; 1990 Jun; 47(6):1304-13. PubMed ID: 2368723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacy services and solid organ transplantation: a literature review.
    Stemer G; Lemmens-Gruber R
    Pharm World Sci; 2010 Feb; 32(1):7-18. PubMed ID: 20012363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care in China: improvement, challenges, and reform.
    Wang C; Rao K; Wu S; Liu Q
    Chest; 2013 Feb; 143(2):524-531. PubMed ID: 23381317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
    Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
    Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.